
Heidi L. Reese
Examiner (ID: 13855)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1657, 1625, 1622 |
| Total Applications | 1608 |
| Issued Applications | 1298 |
| Pending Applications | 5 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11003791
[patent_doc_number] => 20160200739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'ALKYNYL ALCOHOLS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/074100
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 124582
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15074100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/074100 | Alkynyl alcohols and methods of use | Mar 17, 2016 | Issued |
Array
(
[id] => 12779923
[patent_doc_number] => 20180151809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/570401
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570401
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570401 | Organic electroluminescent compounds and organic electroluminescent device comprising the same | Mar 16, 2016 | Issued |
Array
(
[id] => 11024952
[patent_doc_number] => 20160221907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'MTOR-independent activator of TFEB for autophagy enhancement and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/071222
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 13008
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071222 | MTOR-independent activator of TFEB for autophagy enhancement and uses thereof | Mar 15, 2016 | Issued |
Array
(
[id] => 11237461
[patent_doc_number] => 09464094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-11
[patent_title] => 'Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same'
[patent_app_type] => utility
[patent_app_number] => 15/071147
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20166
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071147 | Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same | Mar 14, 2016 | Issued |
Array
(
[id] => 14072179
[patent_doc_number] => 20190084977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => TRICYCLIC KINASE INHIBITORS OF MELK ANDS METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/554595
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554595 | Tricyclic kinase inhibitors of MELK and methods of use | Mar 3, 2016 | Issued |
Array
(
[id] => 12204797
[patent_doc_number] => 20180050023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'OXYBUTYNIN-XANOMELINE TRANSDERMAL THERAPEUTIC SYSTEM COMBINATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/556197
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7882
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556197 | Oxybutynin-xanomeline transdermal therapeutic system combinations | Mar 3, 2016 | Issued |
Array
(
[id] => 13182035
[patent_doc_number] => 10106517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Method for producing tetrahydropyranyl esters
[patent_app_type] => utility
[patent_app_number] => 15/555723
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5131
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555723 | Method for producing tetrahydropyranyl esters | Mar 3, 2016 | Issued |
Array
(
[id] => 12178612
[patent_doc_number] => 20180037549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF PIMAVANSERIN'
[patent_app_type] => utility
[patent_app_number] => 15/555092
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17051
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555092 | Processes and intermediates for the preparation of Pimavanserin | Mar 1, 2016 | Issued |
Array
(
[id] => 12217466
[patent_doc_number] => 20180055826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'METHOD FOR TREATING OBESITY, DIABETES, CARDIOVASCULAR AND KIDNEY DISEASES BY REGULATING GPR30/GPER ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/556055
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 18277
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556055
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556055 | Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity | Mar 1, 2016 | Issued |
Array
(
[id] => 15573965
[patent_doc_number] => 10577349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Quinolinones as inhibitors of translation initiation complex
[patent_app_type] => utility
[patent_app_number] => 15/554419
[patent_app_country] => US
[patent_app_date] => 2016-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 37
[patent_no_of_words] => 39755
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554419 | Quinolinones as inhibitors of translation initiation complex | Feb 29, 2016 | Issued |
Array
(
[id] => 13430959
[patent_doc_number] => 20180267022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => METHOD FOR PREDICTING SIDE EFFECT OF WHITENING INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 15/542263
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542263
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542263 | Method for predicting side effect of whitening ingredient | Feb 25, 2016 | Issued |
Array
(
[id] => 13387165
[patent_doc_number] => 20180245124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => BACTERIA IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TEST
[patent_app_type] => utility
[patent_app_number] => 15/553817
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553817 | Bacteria identification and antimicrobial susceptibility test | Feb 25, 2016 | Issued |
Array
(
[id] => 11284003
[patent_doc_number] => 09499849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Processes for preparing tubulysins'
[patent_app_type] => utility
[patent_app_number] => 15/054342
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12290
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054342
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054342 | Processes for preparing tubulysins | Feb 25, 2016 | Issued |
Array
(
[id] => 11677108
[patent_doc_number] => 09675614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'PRMT5 inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/054193
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50227
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054193 | PRMT5 inhibitors and uses thereof | Feb 25, 2016 | Issued |
Array
(
[id] => 12428091
[patent_doc_number] => 09975871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Continuous arycyclic compound
[patent_app_type] => utility
[patent_app_number] => 15/050154
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23428
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050154 | Continuous arycyclic compound | Feb 21, 2016 | Issued |
Array
(
[id] => 12185412
[patent_doc_number] => 20180044349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'ISOIDIDE MANUFACTURE AND PURIFICATION'
[patent_app_type] => utility
[patent_app_number] => 15/552655
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14595
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552655
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552655 | Isoidide manufacture and purification | Feb 18, 2016 | Issued |
Array
(
[id] => 11463834
[patent_doc_number] => 09580452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Antioxidant compound having anti atherosclerotic effect and preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 15/047872
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6446
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047872 | Antioxidant compound having anti atherosclerotic effect and preparation thereof | Feb 18, 2016 | Issued |
Array
(
[id] => 13645661
[patent_doc_number] => 09849129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Sodium channel blockers for skin disorders
[patent_app_type] => utility
[patent_app_number] => 15/047274
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8847
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047274
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047274 | Sodium channel blockers for skin disorders | Feb 17, 2016 | Issued |
Array
(
[id] => 10813653
[patent_doc_number] => 20160159813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'PROCESS FOR N-DEALKYLATION OF TERTIARY AMINES'
[patent_app_type] => utility
[patent_app_number] => 15/041310
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15274
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041310 | PROCESS FOR N-DEALKYLATION OF TERTIARY AMINES | Feb 10, 2016 | Abandoned |
Array
(
[id] => 10813609
[patent_doc_number] => 20160159768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/040971
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 234558
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040971 | Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same | Feb 9, 2016 | Issued |